Breast reconstruction after mastectomy means choosing between implants and DIEP flap — and radiation therapy changes which option is clinically safer.

Chemo side effects aren't inevitable. A gynecologic oncologist maps AC vs. Taxol, the 3-drug antiemetic protocol, and the ER fever threshold.

Tamoxifen vs aromatase inhibitors: AIs suppress estrogen 95%+ — but only in postmenopausal women. Menopausal status determines your drug, per NCCN 2026.

Breast cancer chemotherapy cycles in waves. Day 1 is rarely the hardest — most patients don't know this. Get the AC-T timeline and NCCN 2026 thresholds.

ost breast cancer radiation patients qualify for 15 sessions, not 25. NCCN 2026 guidelines and ASTRO's cardiac threshold <2 Gy explained.

Lumpectomy vs mastectomy: for Stage I-II, survival rates are equal. Here are the 5 factors surgeons weigh before deciding.

DCIS breast cancer: 99% survival rate when treated, but grade 3 with comedo necrosis changes the surgical decision. A gynecologic oncologist explains.

Metastatic breast cancer treatment in 2026 depends on receptor status — which can change between your original tumor and the metastatic site.

Inflammatory breast cancer is Stage IIIB at every diagnosis per NCCN 2026 — it invades lymphatic vessels in the breast skin, never forming a lump.

HER2-positive breast cancer entered a new treatment era in 2026 after Enhertu reached 92.4% IDFS in DESTINY-Breast05 patients.